These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8314162)

  • 21. The development of cataract in children as a late side-effect of bone marrow transplantation.
    Calissendorff B; Bolme P; el Azazi M
    Bone Marrow Transplant; 1991 Jun; 7(6):427-9. PubMed ID: 1873589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
    Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.
    von Bueltzingsloewen A; Esperou-Bourdeau H; Souillet G; Demeocq F; Mechinaud-Lacroix F; Michel G; Sadoun A; Bernaudin F; Cornu G; Donadieu J
    Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and endocrine function following bone marrow transplantation for thalassemia major.
    Li CK; Chik KW; Wong GW; Cheng PS; Lee V; Shing MM
    Pediatr Hematol Oncol; 2004; 21(5):411-9. PubMed ID: 15205084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
    Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
    Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
    Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Berger C; Le-Gallo B; Donadieu J; Richard O; Devergie A; Galambrun C; Bordigoni P; Vilmer E; Plouvier E; Perel Y; Michel G; Stephan JL
    Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of allogeneic bone marrow transplantation on the endocrine system in children.
    Dopfer R; Ranke MB; Einsele H; Ehninger G; Blum WF; Niethammer D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):541-5. PubMed ID: 2480305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular function in children following bone marrow transplant: a cross-sectional study.
    Eames GM; Crosson J; Steinberger J; Steinbuch M; Krabill K; Bass J; Ramsay NK; Neglia JP
    Bone Marrow Transplant; 1997 Jan; 19(1):61-6. PubMed ID: 9012933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed complications of bone marrow transplantation: an update.
    Buchsel PC; Leum EW; Randolph SR
    Oncol Nurs Forum; 1996 Sep; 23(8):1267-91. PubMed ID: 8883073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
    Frisk P; Bratteby LE; Carlson K; Lönnerholm G
    Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
    Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine complications of high-dose therapy with stem cell transplantation.
    Sanders JE
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():39-50. PubMed ID: 15125705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cataract in children after autologous bone marrow transplantation. A common, but curable complication].
    Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
    Lakartidningen; 2002 Mar; 99(13):1444-7. PubMed ID: 11989353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.